Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)

Glucagon-like Peptide-1 Receptor Agonists—A Potential New Medication for Pediatric Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)

Metabolic-dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease in children in the US and, if untreated, may progress to end-stage liver disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown improvement in MASLD markers in adults with type 2 diab...

Full description

Bibliographic Details
Main Authors: Erika Choi, Ana Ramirez Tovar, Zhulin He, Dellys M. Soler Rodriguez, Miriam B. Vos, Shruthi Arora, Doris Fadoju
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Children
Subjects:
ALT
obesity
liver steatosis
MASLD
GLP-1
Online Access:https://www.mdpi.com/2227-9067/11/3/275

Internet

https://www.mdpi.com/2227-9067/11/3/275

Similar Items